In vitro experiments identified differentiating OBs as potent protectors of AML cells from various apoptosis-inducing agents, such as SDF-1 and standard chemotherapeutics Daunorubicin and Ara-C [158,159,160]. Here, CXCL12 is linked to acute myeloid leukemia.